About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Rimegepant

Company: Nordlandssykehuset HF
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: 14 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

14 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 22, 2026

Trial details

Recruiting NCT NCT04649242

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Not yet reported Pfizer 2100 participants Est. completion 2029-01-09 245 sites

Other conditions: Pediatric Migraine
View official trial listing →
Recruiting NCT NCT04743141

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Not yet reported Pfizer 600 participants Est. completion 2030-07-31 124 sites Stand-alone

Other conditions: Acute Treatment of Migraine
View official trial listing →
Recruiting NCT NCT05046613

Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

Pfizer 780 participants Est. completion 2034-04-30 1 site

Other conditions: Migraine
View official trial listing →
Recruiting NCT NCT05156398

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Not yet reported Pfizer 640 participants Est. completion 2032-11-27 93 sites

Other conditions: Migraine
View official trial listing →
Recruiting NCT NCT05903027

Gepant treAtments: EffectIveNess and tolERability (GAINER)

University of Florence 100 participants Est. completion 2026-09-15 2 sites

Other conditions: Migraine, Migraine With Aura, Migraine Without Aura, Chronic Migraine
View official trial listing →
Recruiting NCT NCT06409832

RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment

University of Florence 100 participants Est. completion 2027-09 2 sites

Other conditions: Migraine, Migraine With Aura, Migraine Without Aura
View official trial listing →
Recruiting NCT NCT06473597

A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache

Not yet reported Antonios Likourezos 80 participants Est. completion 2026-12-31 1 site

Other conditions: Migraine
View official trial listing →
Recruiting NCT NCT06641466

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Not yet reported Pfizer 723 participants Est. completion 2027-03-30 123 sites Stand-alone

Other conditions: Menstrual Migraine
View official trial listing →
Recruiting NCT NCT07103694

i-NEED: NEw migrainE Drugs Database

IRCCS San Raffaele Roma 2641 participants Est. completion 2026-12-31 2 sites

Other conditions: Episodic Migraine, Chronic Migraine, Medication Overuse Headache
View official trial listing →
Recruiting NCT NCT07159750

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

Hospital Universitari Vall d'Hebron Research Institute 700 participants Est. completion 2026-01 26 sites

Other conditions: Migraine, Episodic Migraine, Chronic Migraine, Headache
View official trial listing →
Recruiting NCT NCT07301008

Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US

Not yet reported Medstar Health Research Institute 60 participants Est. completion 2027-01 1 site Stand-alone

Other conditions: Migraine, Trigger Induced Migraine
View official trial listing →
Recruiting NCT NCT07609914

A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

Not yet reported Pfizer 400 participants Est. completion 2028-05-15 14 sites Stand-alone

Other conditions: Acute Treatment of Migraine
View official trial listing →
Recruiting NCT NCT07685769

A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India

Not yet reported Pfizer 60 participants Est. completion 2028-01-04 2 sites

Other conditions: Acute Treatment of Migraine
View official trial listing →
Recruiting NCT NCT07729462

A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine

Not yet reported Pfizer 400 participants Est. completion 2029-01-19 4 sites Stand-alone

Other conditions: Preventive Treatment of Migraine
View official trial listing →
Completed NCT NCT01430442

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Not yet reported Pfizer 1026 participants Est. completion 2012-05 41 sites Stand-alone

Other conditions: Migraine, Acute Treatment of Migraine
View official trial listing →
Completed NCT NCT01445067

Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition

Not yet reported Pfizer 48 participants Est. completion 2012-09 4 sites

Other conditions: Migraine
View official trial listing →
Completed NCT NCT03235479

Safety and Efficacy Study in Adult Subjects With Acute Migraines

Not yet reported Pfizer 1485 participants Est. completion 2018-01-26 50 sites Stand-alone

Other conditions: Migraine, With or Without Aura
View official trial listing →
Completed NCT NCT03237845

Safety and Efficacy in Adult Subjects With Acute Migraines

Not yet reported Pfizer 1499 participants Est. completion 2018-01-31 50 sites Stand-alone

Other conditions: Migraine, With or Without Aura
View official trial listing →
Completed NCT NCT03266588

Open Label Safety Study in Acute Treatment of Migraine

Not yet reported, Not yet reported Pfizer 3019 participants Est. completion 2019-07-15 98 sites Stand-alone

Other conditions: Migraine, With or Without Aura
View official trial listing →
Completed NCT NCT03461757

Trial in Adult Subjects With Acute Migraines

Not yet reported Pfizer 1811 participants Est. completion 2018-10-15 69 sites Stand-alone

Other conditions: Migraine, With or Without Aura
View official trial listing →
Completed NCT NCT03732638

Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults

Not yet reported, Not yet reported Pfizer 1590 participants Est. completion 2021-02-02 93 sites Stand-alone

Other conditions: Migraine
View official trial listing →
No Longer Available NCT NCT03934086

An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine

Pfizer

Other conditions: Migraine
View official trial listing →
Terminated NCT NCT03941834

Trial for Treatment Refractory Trigeminal Neuralgia

Not yet reported Pfizer 65 participants Est. completion 2023-05-11 20 sites

Other conditions: Trigeminal Neuralgia
View official trial listing →
Completed NCT NCT04574362

Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine

Not yet reported Pfizer 1648 participants Est. completion 2021-12-16 90 sites

Other conditions: Acute Migraine
View official trial listing →
Completed NCT NCT04629950

Rimegepant in Moderate Plaque-type Psoriasis

Not yet reported Weill Medical College of Cornell University 41 participants Est. completion 2024-11-18 2 sites Stand-alone

Other conditions: Psoriasis
View official trial listing →
Completed NCT NCT04860713

An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache

Not yet reported Antonios Likourezos 5 participants Est. completion 2022-11-17 1 site

Other conditions: Pain
View official trial listing →
Completed NCT NCT05127486

A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine

Not yet reported Eli Lilly and Company 580 participants Est. completion 2023-05-23 77 sites

Other conditions: Migraine, Episodic Migraine
View official trial listing →
Active, not recruiting NCT NCT05198245

Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy

Pfizer 1 participants Est. completion 2028-04-30 1 site

Other conditions: Migraine
View official trial listing →
Completed NCT NCT05207865

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Not yet reported Pfizer 441 participants Est. completion 2024-07-02 19 sites Stand-alone

Other conditions: Migraine, Episodic Migraine, Phonophobia, Photophobia
View official trial listing →
Terminated NCT NCT05211154

Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine

Not yet reported Danish Headache Center 300 participants Est. completion 2025-04-30 1 site

Other conditions: Migraine With Aura, Migraine Without Aura
View official trial listing →
Completed NCT NCT05217927

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Not yet reported Pfizer 1415 participants Est. completion 2024-12-11 107 sites Stand-alone

Other conditions: Migraine
View official trial listing →
Completed NCT NCT05248997

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Not yet reported Pfizer 261 participants Est. completion 2024-04-02 33 sites

Other conditions: Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
View official trial listing →
Terminated NCT NCT05262517

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

Not yet reported Pfizer 126 participants Est. completion 2023-05-18 32 sites Stand-alone

Other conditions: Temporomandibular Disorders (TMD)
View official trial listing →
Completed NCT NCT05264714

Cluster Headache Treatment With Rimegepant

Not yet reported Mayo Clinic 20 participants Est. completion 2025-12-31 1 site Stand-alone

Other conditions: Cluster Headache
View official trial listing →
Completed NCT NCT05371652

A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants

Not yet reported Pfizer 241 participants Est. completion 2024-02-06 26 sites Stand-alone

Other conditions: Acute Migraine
View official trial listing →
Completed NCT NCT05399459

Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

Not yet reported Pfizer 897 participants Est. completion 2024-01-19 50 sites Stand-alone

Other conditions: Migraine
View official trial listing →
Completed NCT NCT05399485

Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)

Not yet reported Pfizer 496 participants Est. completion 2024-11-07 44 sites Stand-alone

Other conditions: Migraine
View official trial listing →
Completed NCT NCT05509400

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Not yet reported Pfizer 813 participants Est. completion 2025-06-10 93 sites Stand-alone

Other conditions: Migraine
View official trial listing →
Completed NCT NCT05518123

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

Not yet reported Pfizer 962 participants Est. completion 2025-07-08 111 sites Stand-alone

Other conditions: Migraine
View official trial listing →
Completed NCT NCT05709106

A Prospective Real World Study of Rimegepant in the Treatment of Migraine

Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine 173 participants Est. completion 2025-04-09 1 site

Other conditions: Migraine
View official trial listing →
Completed NCT NCT05810038

A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.

Not yet reported Pfizer 787 participants Est. completion 2025-12-10 49 sites Stand-alone

Other conditions: Migraine
View official trial listing →
Status unknown NCT NCT05888766

Predict the Response to Acute Treatment of Migraine With Rimegepant 75 mg

University of Roma La Sapienza 20 participants Est. completion 2024-09-30 1 site

Other conditions: Migraine Disorders
View official trial listing →
Enrolling by invitation NCT NCT06212661

Migraine Medication Effects on Urinary Symptoms

The Cleveland Clinic 200 participants Est. completion 2026-12 1 site

Other conditions: Overactive Bladder, Bladder Pain Syndrome, Migraine Disorders, Overactive Bladder Syndrome, Overactive Detrusor, Migraine, Interstitial Cystitis
View official trial listing →
Completed NCT NCT06221111

Comparison of Rimegepant and Placebo for Pain in IBS

Not yet reported Mayo Clinic 39 participants Est. completion 2025-06-03 1 site Stand-alone

Other conditions: Irritable Bowel Syndrome
View official trial listing →
Completed NCT NCT06221267

A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120 participants Est. completion 2024-06-30 1 site

Other conditions: Migraine
View official trial listing →
Completed NCT NCT06412965

Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine

Pfizer 528 participants Est. completion 2024-01-03 1 site

Other conditions: Migraine Disorders
View official trial listing →
Active, not recruiting NCT NCT06439628

ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine

Chinese PLA General Hospital 3000 participants Est. completion 2027-06-28 3 sites

Other conditions: Migraine
View official trial listing →
Completed NCT NCT06467370

A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.

Pfizer 467 participants Est. completion 2025-03-11 1 site

Other conditions: Migraine
View official trial listing →
Completed NCT NCT06532357

A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.

Pfizer 1536 participants Est. completion 2024-06-10 1 site

Other conditions: Migraine
View official trial listing →
Active, not recruiting NCT NCT06616194

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

Not yet reported Pfizer 200 participants Est. completion 2029-10-13 102 sites Stand-alone

Other conditions: Migraine
View official trial listing →
Completed NCT NCT06680206

Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey

Pfizer 1395 participants Est. completion 2024-11-20 1 site

Other conditions: Migraine
View official trial listing →
Not yet recruiting NCT NCT06728345

The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China

The First Affiliated Hospital of Soochow University 300 participants Est. completion 2027-12-31

Other conditions: Migraine, Migraine Prophylaxis
View official trial listing →
Not yet recruiting NCT NCT06748664

A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment

Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 240 participants Est. completion 2027-05-01 Stand-alone

Other conditions: Vestibular Migraine, Adults 18 Years and Older (no Other Exclusion Criteria)
View official trial listing →
Active, not recruiting NCT NCT06898047

Consistency of Response With Rimegepant in Acute Treatment of Migraine

Pfizer 250 participants Est. completion 2026-10-31 1 site

Other conditions: Migraine
View official trial listing →
Terminated NCT NCT06985342

Acute Migraine Treatment in the ED With Gepants

Not yet reported Icahn School of Medicine at Mount Sinai 9 participants Est. completion 2026-02-04 1 site Stand-alone

Other conditions: Migraine Headaches
View official trial listing →
Active, not recruiting NCT NCT06992674

The R-E-V-I-V-A-L Study

Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 240 participants Est. completion 2026-12-01 1 site Stand-alone

Other conditions: Vestibular Migraine
View official trial listing →
Not yet recruiting NCT NCT06999252

Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients

Not yet reported Fudan University 20 participants Est. completion 2029-06-01 1 site Stand-alone

Other conditions: Colon Cancer
View official trial listing →
Not yet recruiting NCT NCT07435090

Efficacy and Safety of Rimegepant for Acute Dizziness

Not yet reported, Not yet reported Shi Tianming 370 participants Est. completion 2028-06-30 Stand-alone

Other conditions: Dizziness
View official trial listing →
Not yet recruiting NCT NCT07475234

Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma

Not yet reported, Not yet reported Xiuchao Wang 30 participants Est. completion 2028-12 Stand-alone

Other conditions: Metastatic Pancreatic Ductal Adenocarcinoma
View official trial listing →
Not yet recruiting NCT NCT07497854

A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea

Pfizer 3000 participants Est. completion 2030-08-01

Other conditions: Migraine With or Without Aura
View official trial listing →
Not yet recruiting NCT NCT07613788

Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL

Not yet reported Ruijin Hospital 100 participants Est. completion 2029-04 1 site Stand-alone

Other conditions: Relapsed/Refractory Large B-cell Lymphoma (LBCL)
View official trial listing →
Not yet recruiting NCT NCT07655440

Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)

Not yet reported Stanford University 120 participants Est. completion 2031-07 Stand-alone

Other conditions: Migraine Associated Vertigo, Tinnitus, Migraine, Vestibular Migraine
View official trial listing →
Not yet recruiting NCT NCT07667621

A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department

Not yet reported University of South Florida 100 participants Est. completion 2027-08 1 site Stand-alone

Other conditions: Migraine, Migraine Disease, Migraine in Adults, Migraine Headache, Acute Migraine, Migraine Without Aura, Migraine With Aura
View official trial listing →
Not yet recruiting NCT NCT07751497

A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study

Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 400 participants Est. completion 2029-04-01 1 site Stand-alone

Other conditions: Vestibular Migraine
View official trial listing →
Not yet recruiting NCT NCT07795125

Rimegepant For Endometriosis Pain

Not yet reported Mayo Clinic 132 participants Est. completion 2031-09-30 1 site Stand-alone

Other conditions: Endometriosis, Endometriosis-related Pain
View official trial listing →
Not yet recruiting NCT NCT07812467

Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma

Not yet reported Shanghai Zhongshan Hospital 220 participants Est. completion 2033-10-31 1 site Stand-alone

Other conditions: Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (OPSCC)
View official trial listing →
Not yet recruiting NCT NCT07832032

Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine

Nordlandssykehuset HF 60 participants Est. completion 2027-12-31 1 site

Other conditions: Migraine
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT07832032

Also known as: Rimegepant, NURTEC ODT, Rimegepant 75 MG, Vydura

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.